FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer

Future Oncology, Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/2CaEJe1
via IFTTT